Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Dan Peer
Neovac Ltd
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
492
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety, Tolerability, and Immunogenicity of NeomiVac, a Next-Generation mRNA–Lipid Nanoparticle Vaccine Comprising a Novel Ionisable Lipid: A First-In-Human, Phase 1, Dose-Escalation Trial
Number of pages: 1
Posted: 28 Jan 2026
Angelica Vaccaro
,
Jordon Rolt
,
Nicole Frumento
,
Ola Diebold
,
Stephen Laidlaw
,
Susanna Shier
,
Anthony Brown
,
Clement Twumasi
,
Victoria Walker
,
Heinrich Haas
,
James Smith
,
Manuela Zonca
,
Hannah Emami
,
Eran Eilat
,
Dalit Landesman-Milo
,
Fatemeh Moussavi-Pourgharbi
,
Alison M. Lawrie
,
Caroline Maxwell
,
Mwila Kasanyinga
,
Nicola Greenwood
,
Srinivas Ramishetti
,
Denis Besic
,
Surender Vashist
,
Jan Egberts
,
César López-Camacho
,
Adrian V. S. Hill
, Dan Peer,
Miles W. Carroll
,
Eleanor Barnes
and
Paola Cicconi
University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford - Peter Medawar Building for Pathogen Research, University of Oxford, University of Oxford, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, University of Oxford, University of Oxford, University of Oxford, University of Oxford, University of Oxford, Neovac Ltd, Neovac Ltd, Neovac Ltd, Neovac Ltd, University of Oxford, University of Oxford - The Jenner Institute, Neovac Ltd, University of Oxford - Wellcome Trust Centre for Human Genetics, University of Oxford - Peter Medawar Building for Pathogen Research and University of Oxford - Oxford Vaccine Group
Downloads
492
(144,435)
View PDF
Download
Abstract:
mRNA vaccine, novel lipid nanoparticle vaccine (LNP), reactogenicity, immunogenicity, SARS-CoV2
Feedback